Patents Assigned to The Rogosin Institute
  • Patent number: 6303151
    Abstract: A material for suppressing proliferation of cancer cells is produced by entrapping cancer cells in a selectively-permeable structure such as a bead, and culturing the entrapped cells in a culture medium. Entrapment restricts growth of the cancel cells during culturing and causes the cells to produce in the culture medium a material having a molecular weight of at least about 30 kd as measured by filtration that suppresses proliferation of cancer cells. The material is separated from the culture medium by filtering the medium through a filter that separates material having a molecular weight of at least about 30 kd from material having a molecular weight of less than 30 kd. The structure that entraps the cells may contain 10,000 to 500,000 cells. The material or the structure containing the entrapped cells that produce the material can be administered to a subject to suppress cancer cell proliferation.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: October 16, 2001
    Assignee: The Rogosin Institute
    Inventors: Shirin Asina, Kanti Jain, Albert L. Rubin, Barry Smith, Kurt Stenzel
  • Patent number: 5888497
    Abstract: Implantable beads which contain agarose and optionally collagen, and are coated with agarose have incorporated within cells which produce diffusible biological products. The beads may be used as implants to modulate a recipient's immune response. The beads may also be used in an in vitro context to encourage specific types of cells to grow, to produce desirable products in culture, or to suppress growth of certain cells. The implants may also suppress growth of certain cells following administration to a subject. Cancer cells such as renal cancer cells when restricted by being entrapped in the beads produce more of a material that suppresses cancer cell proliferation.
    Type: Grant
    Filed: November 7, 1996
    Date of Patent: March 30, 1999
    Assignee: The Rogosin Institute
    Inventors: Kanti Jain, Albert L. Rubin, Shirin Asina, Barry Smith, Kurt Stenzel
  • Patent number: 5674855
    Abstract: Treatment and prophylaxis of endotoxin caused toxicity is disclosed. This is accomplished by administering phospholipid containing compositions to the subject. The compositions are protein and peptide free, and may contain triglycerides, or other polar or neutral lipids.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 7, 1997
    Assignee: The Rogosin Institute
    Inventors: Daniel M. Levine, Thomas S. Parker, Albert L. Rubin, Bruce R. Gordon, Stuart D. Saal
  • Patent number: 5643569
    Abstract: Biological agents such as secretory cells are encapsulated in a hydrophilic gel made of agarose or collagen-agarose and gelatin sponge-agarose combinations. In a preferred embodiment, semi-solid beads are formed from a suspension containing collagen, agarose and secretory cells such as pancreatic islets, the collagen is polymerized to form solid, agarose-collagen beads and the solid beads are coated with agarose. Coating is preferably by rolling the solid beads in about 5-10% agarose, contacting the rolled beads with mineral oil and washing oil from the beads. Beads containing secretory cells can be transplanted into a mammal to treat a condition caused by impaired secretory cell function.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 1, 1997
    Assignee: The Rogosin Institute
    Inventors: Kanti Jain, Albert L. Rubin, Barry H. Smith
  • Patent number: 5614507
    Abstract: Protein and peptide free compositions are described, which are useful in treating endotoxemia. The compositions contain a phospholipid and a neutral lipid, preferably phosphatidylcholine and triglyceride.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: March 25, 1997
    Assignee: The Rogosin Institute
    Inventors: Thomas S. Parker, Daniel M. Levine, Albert L. Rubin, Bruce R. Gordon, Stuart D. Saal
  • Patent number: 5587366
    Abstract: Treatment and prophylaxis of endotoxin caused toxicity is disclosed. This is accomplished by administering phospholipid containing compositions to the subject. The compositions are protein and peptide free, and may contain triglycerides, or other polar or neutral lipids.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 24, 1996
    Assignee: The Rogosin Institute
    Inventors: Thomas S. Parker, Daniel M. Levine, Albert L. Rubin, Bruce R. Gordon, Stuart D. Saal
  • Patent number: 5506218
    Abstract: Treatment and prophylaxis of endotoxin caused toxicity is disclosed. This is accomplished by administering phospholipid containing compositions to the subject. The compositions are protein and peptide free, and may contain triglycerides, or other polar or neutral lipids.
    Type: Grant
    Filed: August 10, 1994
    Date of Patent: April 9, 1996
    Assignee: The Rogosin Institute
    Inventors: Thomas S. Parker, Daniel M. Levine, Albert L. Rubin, Bruce R. Gordon, Stuart D. Saal
  • Patent number: 5344822
    Abstract: Treatment and prophylaxis of endotoxin caused toxicity is disclosed. This is accomplished by administering a lipid into which the endotoxin of concern is associated, preferably together with a peptide which is not an apolipoprotein. Preferably, the two components are administered in the form of a reconstituted particle, although this is by no means required.
    Type: Grant
    Filed: August 12, 1992
    Date of Patent: September 6, 1994
    Assignee: The Rogosin Institute
    Inventors: Daniel M. Levine, Thomas S. Parker, Albert L. Rubin
  • Patent number: 5128318
    Abstract: A reconstituted high density lipoprotein containing particle is disclosed. The particle is useful in removing excess lipid soluble material from a subject to which it is administered, as well as in delivery of lipid soluble pharmaceuticals to subjects or patients.
    Type: Grant
    Filed: October 27, 1988
    Date of Patent: July 7, 1992
    Assignee: The Rogosin Institute
    Inventors: Daniel M. Levine, Sanford R. Simon, Bruce R. Gordon, Thomas S. Parker, Stuart D. Saal, Albert L. Rubin